Related Experiment Video
Updated: Jan 29, 2026

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder
Tristan Dale1, Jenny Downs2, Heather Olson3
1UWA Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Perth, WA, Australia(1); Telethon Kids Institute, University of Western Australia, Perth, WA, Australia(2).
Insights
Cannabis-based treatments, particularly cannabidiol, show promise for managing seizures in CDKL5 Deficiency Disorder (CDD), a severe pediatric epilepsy. While evidence is emerging, it suggests a potential role for cannabinoids where other therapies fail.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- CDKL5 Deficiency Disorder (CDD) is a severe, early-onset pediatric epilepsy with refractory seizures.
- Current treatments for CDD are often ineffective and carry significant side effects.
- Cannabis-based products have gained attention for potential therapeutic benefits in epilepsy.
Purpose of the Study:
- To provide a comprehensive overview of cannabis and cannabinoids for treating CDD.
- To examine the history, mechanism of action, efficacy, and safety of cannabis-based preparations in CDD.
- To review the burden of CDD and existing treatment limitations.
Main Methods:
- Literature review and synthesis of existing evidence on cannabis and cannabinoids in epilepsy.
- Analysis of anecdotal reports and clinical trial data for CDD.
- Discussion of the pharmacological properties of cannabinoids.
Main Results:
- Cannabinoids, especially cannabidiol (CBD), are effective in other refractory epilepsies like Dravet and Lennox-Gastaut syndromes.
- Anecdotal evidence and an open-label trial suggest CBD reduces seizure activity in CDD.
- Limited but growing evidence supports the use of cannabinoids for CDD.
Conclusions:
- Cannabis-based preparations, particularly CBD, represent a potential therapeutic option for refractory seizures in CDD.
- Further clinical and observational research is warranted to establish the efficacy and safety of cannabinoids in CDD.
- The review highlights the need for regulatory consideration of cannabis-based treatments for severe pediatric epilepsies.
Abstract:
Severe paediatric epilepsies such as CDKL5 Deficiency Disorder (CDD) are extremely debilitating, largely due to the early-onset and refractory nature of the seizures. Existing treatment options are often ineffective and associated with a host of adverse effects, causing those that are affected to seek alternative treatments. Cannabis based products have attracted significant attention over recent years, primarily driven by reports of miraculous cures and a renewed public preference for 'natural' therapies, thus placing intense pressure on health professionals and the government for regulatory change. This study provides a comprehensive overview of the potential role for cannabis in the treatment of CDD. Key areas discussed include the history, mechanism of action, efficacy and safety of cannabis based preparations as well as the burden related to CDD. The evidence supports the use of cannabinoids, especially cannabidiol, in similar forms of refractory epilepsy including Dravet and Lennox-Gastaut syndromes. Evidence for cannabinoids specifically in CDD is limited but growing, with multiple anecdotal reports and an open-label trial showing cannabidiol to be associated with a significant reduction in seizure activity. This review provides the first comprehensive overview of the potential role for cannabis based preparations in the treatment of CDD and provides justification for further clinical and observational research.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Intrinsically Disordered Proteins
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Focusing of Light in the Eye
Coping Strategies: Problem Focused
For example, consider a student who struggles to understand their...